Lymphocyte homing to allografts

Transplantation

Volumn 70, Issue 8, 2000, Pages 1131-1139

  Lalor, P F ^a   Adams, D H ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; CHEMOKINE; LYMPHOCYTE RECEPTOR;

ALLOGRAFT; ANTIGEN RECOGNITION; CELL ADHESION; CELL INTERACTION; ENDOTHELIUM; ENDOTHELIUM CELL; GENE EXPRESSION; GENE EXPRESSION REGULATION; GRAFT REJECTION; HUMAN; LYMPHOCYTE HOMING; LYMPHOCYTE MIGRATION; MEMORY CELL; NONHUMAN; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; TISSUE SPECIFICITY; TRANSPLANTATION;

EID: 0034721823     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200010270-00001     Document Type: Review

References (135)

1. Lymphocyte homing and homeostasis
2. Leucocyte endothelial interactions and regulation of leucocyte migration
3. Endothelial cells in physiology and in the pathophysiology of vascular disorders
4. Lymphocyte migration patterns in organ allograft recipients
5. Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm
6. The selectins: Vascular adhesion molecules
7. The integrin vla-4 supports tethering and rolling in flow on VCAM-1
8. Alpha-4 integrins mediate lymphocyte attachment and rolling under physiological flow
9. Association between receptor density, cellular activation, and transformation of adhesive behavior of flowing lymphocytes binding to VCAM-1
10. Biology of chemokine and classical chemoattractant receptors - Differential requirements for adhesion-triggering versus chemotactic responses in lymphoid-cells
11. Chemokines - Chemotactic cytokines that mediate inflammation
12. Chemokines: Leucocyte recruitment and activation cytokines
13. Differential regulation and function of cd73, a glycosylphosphatidylinositol-linked 70-kd adhesion molecule, on lymphocytes and endothelial cells
14. CD31 expressed on distinctive T cell subsets is a preferential amplifier of β1 integrin-mediated adhesion
15. The c-c chemokine mcp-1 differentially modulates the avidity of beta- 1 and beta-2 integrins on t-lymphocytes
16. T-cell adhesion induced by proteoglycan-immobilized cytokine MIP-1β
17. Chemokines and the arrest of lymphocytes rolling under flow conditions
18. Chemokines in tissue-specific and microenvironment-specific lymphocyte homing
19. How do lymphocytes know where to go: Current concepts and enigmas of lymphoctye homing
20. Molecular mechanisms of lymphocyte homing to peripheral lymph nodes
21. Chemokines and cell migration in secondary lymphoid organs
22. Mice lacking expression of secondary lymphoid organ chemokine have defects in lymphocyte homing and dendritic cell localization
23. Distinct roles of l-selectin and integrins alpha-4-beta-7 and lfa-1 in lymphocyte homing to peyers patch-hev in-situ - The multistep model confirmed and refined
24. High endothelial venules (HEVs): Specialized endothelium for lymphocyte migration
25. A chemokine expressed in lymphoid high endothelial venules promotes the adhesion and chemotaxis of naive T lymphocytes
26. Chemokines and the homing of dendritic cells to the T cell areas of lymphoid organs
27. Homing of naive, memory and effector lymphocytes
28. Four molecular pathways of T cell adhesion to endothelial cells: Roles of LFA-1, VCAM-1 and ELAM-1 and changes in pathway hierarchy under different activation conditions
29. The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions
30. Chemokine and chemokine receptor interactions provide a mechanism for selective T cell recruitment to specific liver compartments within hepatitis C infected liver
31. The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes
32. Switch in chemokine receptor expression upon TCR stimulation reveals novel homing potential for recently activated T cells
33. Enhancement of LFA-1-mediated cell adhesion by triggering through CD2 or CD3 on T lymphocytes
34. The role of CCR7 in TH1 and TH2 cell localization and delivery of B cell help in vivo
35. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions
36. What is the role of regulatory T cells in transplantation tolerance?
37. Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes
38. P- and E-selectin mediate recruitment of T-helper-1 but not T-helper-2 cells into inflammed tissues
39. P-selectin glycoprotein ligand-1 (PSGL-1) on T helper 1 but not on T helper 2 cells binds to P-selectin and supports migration into inflamed skin
40. The binding of T cell-expressed P-selectin glycoprotein ligand-1 to E- and P-selectin is differentially regulated
41. Differential expression of alpha3 fucosyltransferases in Th1 and Th2 cells correlates with their ability to bind P-selectin
42. Alpha(1,3)-fucosyltransferase VII and alpha(2,3)-sialyltransferase IV are up-regulated in activated CD4 T cells and maintained after their differentiation into Th1 and migration into inflammatory sites
43. Tissue specificity of E- and P-selectin ligands in Th1-mediated chronic inflammation
44. Expression of functional selectin ligands on Th cells is differentially regulated by IL-12 and IL-4
45. Alpha 4 beta 7 integrin mediates binding to the mucosal vascular addressin MAdCAM-1
46. Cutaneous lymphocyte antigen is a specialized form of PSGL-1 expressed on skin-homing T cells
47. Control of lymphocyte recirculation in man. II. Differential regulation of the cutaneous lymphocyte-associated antigen, a tissue-selective homing receptor for skin-homing T cells
48. Expression of E-selectin (CD62E) and E-selectin ligands in human liver inflammation
49. ELAM-1 is an adhesion molecule for skin-homing T cells
50. Lymphocyte trafficking in the intestine and liver
51. Vascular adhesion protein-1 and ICAM-1 support the adhesion of tumor infiltrating lymphocytes to tumor endothelium in human hepatocellular carcinoma
52. Vascular adhesion protein 1 mediates binding of T cells to human hepatic endothelium
53. Differential expression of homing molecules on recirculating lymphocytes from sheep gut, peripheral, and lung lymph
54. Lung epithelial lining fluid t-cell subsets defined by distinct patterns of beta-7 and beta-1 integrin expression
55. Lymphocyte recruitment and the kinetics of adhesion receptor expression during the pulmonary immune response to particulate antigen
56. The chemokine receptor CCR4 in vascular recognition by cutaneous but not intestinal memory T cells
57. Dual personality of memory T cells
58. Control of lymphocyte recirculation in man: I. Differential regulation of the peripheral lymph node homing receptor L-selectin on T cells during the virgin to memory cell transition
59. Lymphotoxin alpha3 induces chemokines and adhesion molecules: Insight into the role of LT alpha in inflammation and lymphoid organ development
60. Orchestrated information-transfer underlying leukocyte-endothelial interactions
61. Endothelial-leukocyte adhesion molecules
62. Orchestrated information transfer underlying leukocyte endothelial interactions
63. Regulation of endothelial VCAM-1 expression in murine cardiac grafts. Roles for TNF and IL-4
64. Contrasting efffects of interferon gamma and interleukin 4 on responses of human vascular endothelial cells to tumour necrosis factor alpha
65. IFN-gamma inhibits activation-induced expression of E- and P-selectin on endothelial cells
66. P-selectin mediates neutrophil rolling on histamine stimulated endothelial cells
67. Intercellular-adhesion molecule-1 mediates the expression of monocyte-derived mip-1-alpha during monocyte endothelial-cell interactions
68. Ligation of ICAM-1 on endothelial cells leads to expression of VCAM-1 via a nuclear factor-kappaB-independent mechanism
69. Lymphocyte migration through brain endothelial cell monolayers involves signaling through endothelial ICAM-1 via a rho-dependent pathway
70. CD40 activation induces apoptosis in cultured human hepatocytes via induction of cell surface FasL expression and amplifies Fas mediated hepatocyte death during allograft rejection
71. Cd40 on human endothelial-cells - Inducibility by cytokines and functional regulation of adhesion molecule expression
72. Chemokines: Function, regulation and alteration of inflammatory responses
73. Stimulus and cell-specific expression of c-x-c and c-c chemokines by pulmonary stromal cell-populations
74. Mig and IP-10; chemokine that target lymphocytes
75. CD8+ myelin peptide-specific T cells can chemoattract CD4+ myelin peptide-specific T cells: Importance of IFN-inducible protein 10
76. Some aspects of IL-8 pathophysiology. III. Chemokine interaction with endothelial cells
77. The promiscuous chemokine binding profile of the Duffy antigen/receptor for chemokines is primarily localized to sequences in the amino-terminal domain
78. Binding of RANTES, MCP-1, MCP-3, and MIP-1alpha to cells in human skin
79. Differential binding of chemokines to glycosaminoglycan subpopulations
80. Transcytosis and surface presentation of IL-8 by venular endothelial cells
81. Binding of RANTES, MCP-1, MCP-3, and MIP-1alpha to cells in human skin
82. Endothelial cell 'memory' of inflammatory stimulation: Human venular endothelial cells store interleukin 8 in Weibel-Palade bodies
83. Interactions between T lymphocytes and endothelial cells in allograft rejection
84. RANTES chemokine expression in cell-mediated transplant rejection of the kidney
85. Hepatic expression of macrophage inflammatory protein-1α and macrophage inflammatory protein-1β after liver transplantation
86. CD8+ T cells produce RANTES during acute rejection of murine allogeneic skin grafts
87. Preservation injury: Mechanisms, prevention and consequences
88. Effects of initial ischemia/reperfusion injury on the transplanted kidney
89. Natural adjuvants: Endogenous activators of dendritic cells
90. Chronic graft-rejection
91. Cold ischemic injury accelerates the progression to chronic rejection in a rat cardiac allograft model
92. Endothelial activation and cytokine expression in human cardiac allograft rejection
93. The release of cytokines, adhesion molecules and extracellular matrix parameters during and after reperfusion in human liver transplantation
94. Carbohydrate selectin inhibitor CY-1503 reduces neutrophil migration and reperfusion injury in canine pulmonary allografts
95. Anti-rejection prophylaxis by blocking selectin dependent cell adhesion after rat allogeneic and xenogeneic lung transplantation
96. Prediction of the outcome of transplantation in man by platelet adherence in donor liver allografts. Evidence of the importance of prepreservation injury
97. Platelet-mediated lymphocyte delivery to high endothelial venules
98. Endothelial ligands for L-selectin: From lymphocyte recirculation to allograft rejection
99. L-selectin is involved in lymphocyte migration to sites of inflammation in the skin: Delayed rejection of allografts in L-selectin-deficient mice
100. Sialyl lewis(x)-dependent and 1-selectin-dependent site-specific lymphocyte extravasation into renal-transplants during acute rejection
101. Endothelial L-selectin ligands are likely to recruit lymphocytes into rejecting human heart transplants
102. De novo expression of endothelial sialyl Lewis(a) and sialyl Lewis(x) during cardiac transplant rejection: Superior capacity of a tetravalent sialyl Lewis(x) oligosaccharide in inhibiting L-selectin-dependent lymphocyte adhesion
103. Enzymatic synthesis of alpha3'sialylated and multiply alpha3fucosylated biantennary polylactosamines. A bivalent [sialyl diLex]-saccharide inhibited lymphocyte-endothelium adhesion organ-selectively
104. Vascular adhesion protein-1 supports adhesion of T lymphocytes to hepatic endothelium. A mechanism for T cell recirculation to the liver?
105. Human mucosal addressin cell adhesion molecule-1 is preferentially expressed in intestinal tract and associated lymphoid tissue
106. Pig lymphocytes utilise mouse MAdCAM-1 to enter fetal gut xenografts in SCID mice
107. Down-modulation of host reactivity by anti-CD44 in skin transplantation
108. Binding of lymphocytes to acutely rejecting rat kidney allografts in vitro is guided by events in the graft itself rather than by sensitization of host lymphocytes
109. Evidence that lymphocyte traffic into rejecting cardiac allografts is CD11a and CD49d-dependent
110. T lymphocyte adhesion mechanisms within inflamed human kidney: Studies with a Stamper-Woodruff assay
111. Differential regulation of rejection of small intestinal and skin allografts in rats by injection of antibodies to ICAM-1 or the integrins alpha 4, alpha L, or beta 2
112. Antibody to CD18 reduces neutrophil and T lymphocyte infiltration and vascular cell adhesion molecule-1 expression in cardiac rejection
113. Altered patterns of migration of cytokine-producing T lymphocytes in skin-grafted naive or immune mice following in vivo administration of anti-VCAM-1 or -ICAM-1
114. Immunosuppression by anti-ICAM-1 and anti-LFA-1 monoclonal antibodies of free and vascularized skin allograft rejection
115. Regulation of endothelial VCAM-1 expression in murine cardiac grafts. Expression of allograft endothelial VCAM-1 can be manipulated with antagonist of IFN-alpha or IL-4 and is not required for allograft rejection
116. The efficacy of lfa-1 and vla-4 antibody treatment in rat vascularized cardiac allograft-rejection
117. Prolongation of rat islet allograft survival by treatment with monoclonal-antibodies against vla-4 and lfa-1
118. Immunosuppression by blocking alpha 4-integrins/VCAM-1 adhesion
119. Effect of anti-LFA1 (CD11a) monoclonal antibodies in acute rejection in human kidney transplantation
120. A phase I trial of immunosuppression with anti-ICAM-1 (CD54) mAb in renal allograft recipients
121. A randomized multicenter trial of the anti-ICAM-1 monoclonal antibody (enlimomab) for the prevention of acute rejection and delayed onset of graft function in cadaveric renal transplantation: A report of the European Anti-ICAM-1 Renal Transplant Study Group
122. Chemokines and their receptors in leukocyte trafficking and renal inflammation
123. Sequential cellular and molecular kinetics in acutely rejecting renal allografts in rats
124. Sequential cytokine dynamics in chronic rejection of rat renal allografts: Roles for cytokines RANTES and MCP-1
125. T cell-dependent acceleration of chemoattractant cytokine gene expression during secondary rejection of allogeneic skin grafts
126. Met-RANTES reduces vascular and tubular damage during acute renal transplant rejection: Blocking monocyte arrest and recruitment
127. Targeting of the chemokine receptor CCR1 suppresses development of acute and chronic cardiac allograft rejection
128. Expression of the C-C chemokine receptor 5 in human kidney diseases
129. CCR5(+) and CXCR3(+) T cells are increased in multiple sclerosis and their ligands MIP-1alpha and IP-10 are expressed in demyelinating brain lesions
130. Expression of chemokine genes during rejection and longterm acceptance of cardiac allografts
131. Endothelial cells modify the costimulatory capacity of transmigrating leukocytes and promote CD28-mediated CD4(+) T cell alloactivation
132. Can graft endothelial cells initiate a host anti-graft immune response?
133. Antigen recognition influences transendothelial migration of CD4+ T cells
134. Diapedesis of leukocytes: Antisense oligonucleotides for rescue
135. Lack of chemokine receptor CCR1 enhances Th1 responses and glomerular injury during nephrotoxic